# Pycnogenol Blood Pressure Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/pycnogenol-blood-pressure-meta-analysis-evidence-review
Category: evidence-review
Summary: Pycnogenol Blood Pressure Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are
Last reviewed: 2026-06-15
Reviewed by: Migaku Evidence Review
# Pycnogenol Blood Pressure Meta-analysis: What the Evidence Says

## Quick Answer

Pycnogenol Blood Pressure Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 narrative review, 1 research article.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| The efficacy and safety of herbal medicines for glycaemic control and insulin resistance in individuals with type 2 diabetes: an umbrella review | narrative review | 3 | 2025-09-30 | 10.1186/s12906-025-05059-7 |
| Rhabdomyolysis Associated With Excess Pine Bark Extract: A Case Report | research article | 4 | 2025-10-06 | 10.7759/cureus.93956 |

## What The Sources Report

- However, despite their efficacy, hypoglycaemic medications are associated with varying costs and side effect profiles that may influence a patient's decision to seek other interventions, including herbal medicine. [Li Ethan (2025); evidence level 3]
- There is limited evidence on how herbal medicine may interact with Western pharmaceuticals. [Li Ethan (2025); evidence level 3]
- However, even in high-intensity training, which poses an increased risk for rhabdomyolysis compared to other exertive activities, CK levels rarely exceed 100,000 U/L. [Muacevic Alexander (2025); evidence level 4]
- At recommended dosages, pine bark extract has a favorable safety profile, with minimal side effects and no evidence of severe muscle toxicity, as supported by comprehensive systematic reviews and meta-analyses. [Muacevic Alexander (2025); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

For pycnogenol blood pressure meta-analysis, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Li Ethan (2025). The efficacy and safety of herbal medicines for glycaemic control and insulin resistance in individuals with type 2 diabetes: an umbrella review. DOI: 10.1186/s12906-025-05059-7. PMCID: PMC12481776. PMID: 41029669. License: https://creativecommons.org/licenses/by-nc-nd/4.0/ http://creativecommons.org/licenses/by-nc-nd/4.0/ This article is .... https://pmc.ncbi.nlm.nih.gov/articles/PMC12481776/
- Muacevic Alexander (2025). Rhabdomyolysis Associated With Excess Pine Bark Extract: A Case Report. DOI: 10.7759/cureus.93956. PMCID: PMC12588601. PMID: 41200632. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12588601/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.